Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Cordstem-ST in Patients With Cerebral Infarction


Phase 1/2 Results N/A

Summary of Purpose

The objective of the study is to evaluate the safety and the potential therapeutic effects per dose of Cordstem-ST Intravenous Transplantation in Cerebral Infarction subjects comprised of 2 treatment cohorts: Cohort 1 : Cordstem-ST 2.0 x 10^8 cells or Placebo on day 0 Cohort 2: Cordstem-ST 2.0 x 10^8 cells or Placebo on day 0 and day 7

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 July 2016.

1 Feb 2015 16 Feb 2015 1 Feb 2018 Unavailable 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment